Increasing bowel cancer screening using SMS in general practice: the SMARTscreen trial

CONCLUSION: The SMS increased NBCSP kit return in 50-to-60-year-old general practice patients. This finding informed a larger trial -SMARTERscreen- to test this intervention in a broader Australian population.PMID:38164588 | DOI:10.3399/BJGP.2023.0230

Source: Cancer Control - January 2, 2024 Category: Cancer & Oncology Authors: Jennifer G McIntosh Mark A Jenkins Anna Wood Patty Chondros Tina Campbell Edweana Wenkart Clare O'Reilly Ian Dixon Julie Toner Javiera Martinez Gutierrez Linda Govan Jon Emery Source Type: research